Cardiologist, Massachusetts General Hospital Investigator, Harvard Clinical Research Institute Assistant Professor, Harvar Medical School
Cardiology
Dr. Hanna K. Gaggin, MD
|
|
Give Review
Hanna Gaggin is an expert in the field of Cardiology. He studied medicine at Eastern Virginia Medical School. He received 1 awards: "Fellow (FACC)". Hanna Gaggin is a published MD. He published 20 publications, including: 'Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in heart failure: A multicenter study.' Doctor Hanna K. Gaggin, MD accepts Medicare payments and is listed with Medicare.gov.
Publications
- Prediction of survival and magnitude of reverse remodeling using the ST2-R2 score in Heart failure: A multicenter study.
- Galectin-3 and mineralocorticoid receptor antagonist use in patients with Chronic heart failure due to left ventricular systolic dysfunction.
- Concentrations of Highly Sensitive Cardiac Troponin-I Predict Poor Cardiovascular Outcomes and Adverse Remodeling in Chronic Heart Failure.
- Characterization and Prediction of Adverse Events From Intensive Chronic Heart Failure Management and Effect on Quality of Life: Results From the Pro-B-Type Natriureti...
- Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?
- Different vascular responses within the same stent detected by optical coherence tomography.
- Measurement of novel biomarkers to predict Chronic heart failure outcomes and left ventricular remodeling.
- Natriuretic Peptides in Heart Failure and Acute Coronary Syndrome.
- Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure.
- Reference Interval Evaluation of High Sensitivity Troponin T and N-Terminal B-Type Natriuretic Peptide in Vietnam and the US: The North South East West Trial.
- The Role of Treatment for Anemia as a Therapeutic Target in the Management of Chronic Heart Failure: Insights After RED-HF.
- Soluble Concentrations of the Interleukin Receptor Family Member ST2 and β-Blocker Therapy in Chronic Heart Failure.
- Serial measurement of galectin-3 in patients with Chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study.
- Biomarkers and diagnostics in Heart failure.
- Characterization and Prediction of Natriuretic Peptide "Nonresponse" During Heart Failure Management: Results From the ProBNP Outpatient Tailored Chronic Heart Failure...
- Improvement in structural and functional echocardiographic parameters during Chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from th...
- Quality of life and Chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) s...
- Heart Failure Outcomes and Benefits of NT-proBNP-Guided Management in the Elderly: Results From the Prospective, Randomized ProBNP Outpatient Tailored Chronic Heart Fa...
- What is the role of serial high-sensitivity troponin measurements in Chronic heart failure?
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- Cardiomegaly
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- Fellow (FACC)
Education
-
University of Pittsburgh Medical Center -
University of Virginia -
Eastern Virginia Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1760597728 | |
| NPPES Provider LastName | GAGGIN | |
| NPPES Provider FirstName | HANNA | |
| NPPES Provider ZIPCode | 021142621 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 155.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760597728 |
| Last Name Of The Provider | GAGGIN |
| First Name Of The Provider | HANNA |
| View All |
Similar Doctors
|
|
Dr. Aidan W. Flynn, MD |
|
|
Dr. Regina L. Sohn, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin R. King, MD |
|
|
Dr. Jae B. Kim, MD |
|
|
Dr. Francine K. Welty, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ravi Dhingra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ravi M. Lala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shivda Pandey, MD |
|
|
Veerendra M. Chadachan
This Doctor is OpenDoctor Recommended.
|